News for NeuroScientific Biopharmaceuticals Limited (NSB.AX)

Published at

Mar 29, 2024 6:47 PM

by gurufocus.com

positive

positive

NeuroScientific Biopharmaceuticals Ltd at Vertical Events Gold Coast Investment Showcase Transcript

Jun 23, 2022 / 03:00AM GMTUnidentified Participant (audio already in progress) finally coming to fruition. NeuroScientific Biopharmaceuticals is a drug developm

NSB.AX

Read more →
Published at

Dec 1, 2023 7:26 AM

by themarketherald.com.au

mixed

mixed

TMH Market Close: First day of December down after November rally

The ASX200 finished off the first day of December down 0.2 of a percent - with all sectors, except energy, losing some ground.

PRS.AX PMV.AX NSB.AX GLH.AX COL.AX 4DX.AX

Read more →
Published at

Feb 2, 2023 6:37 AM

by stockhead.com.au

mixed

mixed

CLOSING BELL: Adani and The Crown go head-to-head to see who can lose the most face in one day

The ASX ran out of puff to end just 0.2% higher, Spacetalk kept soaring and King Charles III has been booted of the Aussie $5 note.

WFL.AX SPA.AX SND.AX RWD.AX NSB.AX NEA.AX NCZ.AX NAE.AX MME.AX MHC.AX JAL.AX GLL.AX DRO.AX CAZ.AX ZMM.AX YPB.AX VKA.AX SRJ.AX SLZ.AX QFY.AX LDR.AX GLV.AX DTR.AX CPT.AX CLE.AX AVR.AX AMD.AX 88E.AX WEL.AX SMX.AX ATU.AX

Read more →
Published at

Feb 2, 2023 5:34 AM

by themarketherald.com.au

positive

positive

NeuroScientific Biopharmaceuticals (ASX:NSB) secures $3.7m tax incentive refund

NeuroScientific Biopharmaceuticals (ASX:NSB) has pocketed a $3.7 million tax incentive refund from the Australian Federal Government.

NSB.AX

Read more →
Published at

Nov 23, 2022 2:50 AM

by themarketherald.com.au

neutral

neutral

NeuroScientific Biopharmaceuticals (ASX:NSB) appoints Paul Rennie as interim CEO

NeuroScientific Biopharmaceuticals (ASX:NSB) has appointed Paul Rennie as interim CEO, nearly three months after the company's former CEO and Managing Director resigned.

NSB.AX

Read more →
Published at

Sep 9, 2022 4:29 AM

by themarketherald.com.au

neutral

neutral

NeuroScientific Biopharmaceuticals (ASX:NSB) CEO and Managing Director resigns

NeuroScientific Biopharmaceuticals (ASX:NSB) CEO and Managing Director Matt Liddelow resigns from the company.

NSB.AX

Read more →
Published at

Sep 7, 2022 5:47 AM

by stockhead.com.au

mixed

mixed

ASX Small Caps News Wrap: Who else reckons it’s turtles all the way down?

The ASX has fallen, some miners are bucking the trend and we are quite clearly living in a simulation.

THR.L THR.AX THORF SI6.AX SGQ.AX NMT.AX MTH.AX MEB.AX MDBIF MCM.AX ICT.AX CNJ.AX CLE.AX CFO.AX CFFMF BXN.AX BWNAF BOA.AX BAT.AX ROG.AX NAE.AX MFB.AX INTZ HCT.AX GTG.AX GENE EMT.AX EMP.AX CPT.AX CHN.AX BDG.AX AMT.AX WEC.AX NSB.AX MOB.AX

Read more →
Published at

Sep 7, 2022 2:42 AM

by stockhead.com.au

mixed

mixed

Top 10 at 10: More lithium potential, high grade copper, and ‘Australia’s next rare earths producer’ raises big bucks

Top 10 at 10: More lithium potential, high grade copper, and ‘Australia’s next rare earths producer’ raises big bucks

SI6.AX BWNAF SGQ.AX MEB.AX MDBIF MCM.AX HAS.AX ROG.AX NSB.AX NAE.AX AUH.AX ANL.AX AMT.AX ADR.AX

Read more →
Published at

Sep 7, 2022 1:33 AM

by themarketherald.com.au

neutral

neutral

Neuroscientific Biopharmaceuticals (ASX:NSB) hit with phase one clinical trial rejection

Neuroscientific Biopharmaceuticals (ASX:NSB) astounded investors this morning with the news its phase one clinical trial has been rejected.

NSB.AX

Read more →
Published at

Aug 30, 2022 10:05 PM

by stockhead.com.au

neutral

neutral

NeuroScientific achieves key milestones in FY22, advancing lead drug EmtinB for treatment of MS

NeuroScientific Biopharmaceuticals (ASX:NSB) has started the clinical development program for its lead drug EmtinBTM.

NSB.AX

Read more →
Published at

Aug 20, 2021 8:34 AM

by stockhead.com.au

mixed

mixed

Closing Bell: ASX down 2.2pc for the week

Closing Bell: ASX down 2.2pc for the week

TRN.AX TAO.AX S2R.AX NSB.AX NOX.AX MQR.AX LPI.AX IHR.AX HYM.AX DC2.AX COD.AX BEM.AX BCN.AX AVL.AX APZ.AX 2BE.AX LNU.AX ANG.AX WHK.AX VMS.AX VIC.AX VAL.AX SRK.AX RDBBY RDBBF RBL.AX PUFLF PTR.AX PO3.AX PKD.AX OIEXF OEX.L OEX.AX NGY.AX NAG.AX MCT.AX LBT.AX IDT.AX ICL.AX GW1.AX GRL.AX GBE.AX GAL.AX FRB.AX FNT.AX FEL.AX ESH.AX DDD.AX BSMDA.AX AXE.AX AMS.AX ADS.AX

Read more →
Published at

Jul 1, 2021 8:39 AM

by stockhead.com.au

mixed

mixed

Last Orders: ASX begins FY22 down 0.65 per cent

Last Orders: ASX begins FY22 down 0.65 per cent

TEK.AX SGC.AX SEG.AX RDG.AX RAS.AX PXS.AX NSB.AX NOV.AX MX1.AX IPH.AX FZO.AX BTC.AX AVZ.AX AGR.AX LLC.AX BBL.AX

Read more →
Published at

Jun 30, 2021 11:09 PM

by stockhead.com.au

mixed

mixed

Rise and Shine: What you need to know before the ASX opens

On Stockhead today, five ASX tech stocks to watch, the ASX-listed drillers poised to benefit from the mining exploration boom, and lithium veteran Chris

ZMM.AX TEM.AX SYA.AX RHP.AX RAN.AX QFY.AX PUFLF PO3.AX OAR.AX NXLLF NXL.AX NSB.AX NOV.AX MLS.AX LCK.AX FGO.AX EVE.AX EN1.AX CAV.AX BSM.AX AVZ.AX AGR.AX AFW.AX AFA.AX ADN.AX ZER.AX CIO.AX TER.AX RKN.AX PKD.AX MR1.AX IOD.AX CLZ.AX CE1.AX

Read more →
Published at

Jun 30, 2021 8:21 AM

by stockhead.com.au

positive

positive

Last Orders: ASX rebounds from its COVID jitters earlier this week

Last Orders: ASX rebounds from its COVID jitters earlier this week

TER.AX SYA.AX SPA.AX RHP.AX NSB.AX NOV.AX LCK.AX EPX.AX AVZ.AX AMS.AX AGR.AX AFW.AX ADN.AX

Read more →